218 related articles for article (PubMed ID: 17983732)
21. Safety profile of cefditoren. A pooled analysis of data from clinical trials in community-acquired respiratory tract infections.
Granizo JJ; Aguilar L; Gimenez MJ; Coronel P; Gimeno M; Prieto J
Rev Esp Quimioter; 2009 Jun; 22(2):57-61. PubMed ID: 19544097
[TBL] [Abstract][Full Text] [Related]
22. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate.
Lipsky BA; Giordano P; Choudhri S; Song J
J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812
[TBL] [Abstract][Full Text] [Related]
23. Overview of newer antimicrobial formulations for overcoming pneumococcal resistance.
Craig WA
Am J Med; 2004 Aug; 117 Suppl 3A():16S-22S. PubMed ID: 15360093
[TBL] [Abstract][Full Text] [Related]
24. Amoxicillin/clavulanate potassium extended release tablets: a new antimicrobial for the treatment of acute bacterial sinusitis and community-acquired pneumonia.
Benninger MS
Expert Opin Pharmacother; 2003 Oct; 4(10):1839-46. PubMed ID: 14521493
[TBL] [Abstract][Full Text] [Related]
25. High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial.
Matho A; Mulqueen M; Tanino M; Quidort A; Cheung J; Pollard J; Rodriguez J; Swamy S; Tayler B; Garrison G; Ata A; Sorum P
PLoS One; 2018; 13(5):e0196734. PubMed ID: 29738561
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children.
Wald ER; Nash D; Eickhoff J
Pediatrics; 2009 Jul; 124(1):9-15. PubMed ID: 19564277
[TBL] [Abstract][Full Text] [Related]
27. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis.
Brook I
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313
[No Abstract] [Full Text] [Related]
28. [The efficacy and safety of cefixime and amoxicillin/clavulanate in the treatment of asymptomatic bacteriuria in pregnant women: a randomized, prospective, multicenter study].
Rafal'skiĭ VV; Dovgan' EV; Kozyrev IuV; Gustovarova TA; Khlybova SV; Novoselova AV; Filippenko NG; Likhikh DG
Urologiia; 2013; (5):24, 26-8. PubMed ID: 24437236
[TBL] [Abstract][Full Text] [Related]
29. Amoxicillin/clavulanate (Augmentin) resistant Escherichia coli in bacterial peritonitis after abdominal surgery--clinical outcome in ICU patients.
Rahnama'i MS; Wagenvoort JH; van der Linden CJ
Neth J Med; 2009 May; 67(5):173-6. PubMed ID: 19581666
[TBL] [Abstract][Full Text] [Related]
30. Study of the efficacy of amoxicillin plus clavulanic acid in the treatment of ear, nose and throat infections.
Ottaviani A; Pagano A; Sambataro G; Berto M; Lenzi A; Mascheroni E
J Chemother; 1989 Jul; 1(4 Suppl):752-4. PubMed ID: 16312622
[No Abstract] [Full Text] [Related]
31. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
Tan TH; Tay L; Yeo M; Feng PH
Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
[No Abstract] [Full Text] [Related]
32. Dose timing and patient compliance with two antibiotic treatment regimens for lower respiratory tract infections in primary care.
Cals JW; Hopstaken RM; Le Doux PH; Driessen GA; Nelemans PJ; Dinant GJ
Int J Antimicrob Agents; 2008 Jun; 31(6):531-6. PubMed ID: 18457936
[TBL] [Abstract][Full Text] [Related]
33. Proof of concept: performance testing in models.
Craig WA
Clin Microbiol Infect; 2004 Apr; 10 Suppl 2():12-7. PubMed ID: 14759229
[TBL] [Abstract][Full Text] [Related]
34. [Why is the augmentin dose changing?].
Chahwakilian P
Presse Med; 2000 Sep; 29(26 Suppl):5-7. PubMed ID: 11045111
[No Abstract] [Full Text] [Related]
35. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
36. [Lower urinary tract infections: bacterial epidemiology and recommendations].
Bergogne-Bérézin E
Prog Urol; 2008 Feb; 18(1 Suppl FMC):F11-4. PubMed ID: 18773847
[TBL] [Abstract][Full Text] [Related]
37. [Comparative efficacy and safety of amoxiclav (amoxicillin clavulanate) and ampicillin in the treatment of acute bacterial sinusitis].
Kriukov AI; Sedinkin AA
Vestn Otorinolaringol; 2004; (1):49-50. PubMed ID: 15029125
[TBL] [Abstract][Full Text] [Related]
38. Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics.
Munckhof WJ; Carney J; Neilson G; Neilson J; Carroll J; McWhinney B; Whitby M
Int J Antimicrob Agents; 2005 Jun; 25(6):514-22. PubMed ID: 15878264
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of amoxicillin-clavulanic acid (Xiclav) efficacy and the possibility of early switch from parenteral to oral therapy in the treatment of infections].
Ahmetagić S; Jusufović E; Cengić D; Koluder N; Bajramović N; Calkić L; Hadzić E; Salaka U; Sijercić M
Med Arh; 2003; 57(5-6):263-6. PubMed ID: 15022575
[TBL] [Abstract][Full Text] [Related]
40. Acute otitis media: making sense of recent guidelines on antimicrobial treatment.
Pichichero ME; Casey JR
J Fam Pract; 2005 Apr; 54(4):313-22. PubMed ID: 15833221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
